关注
Sandile Cele
Sandile Cele
Africa Health Research Institute; University of KwaZulu-Natal
在 ahri.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
S Cele, L Jackson, DS Khoury, K Khan, T Moyo-Gwete, H Tegally, JE San, ...
Nature 602 (7898), 654-656, 2022
10312022
Escape of SARS-CoV-2 501Y. V2 from neutralization by convalescent plasma
S Cele, I Gazy, L Jackson, SH Hwa, H Tegally, G Lustig, J Giandhari, ...
Nature 593 (7857), 142-146, 2021
6722021
T cell responses to SARS-CoV-2 spike cross-recognize Omicron
R Keeton, MB Tincho, A Ngomti, R Baguma, N Benede, A Suzuki, K Khan, ...
Nature 603 (7901), 488-492, 2022
4952022
SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection
S Cele, L Jackson, DS Khoury, K Khan, T Moyo-Gwete, H Tegally, JE San, ...
MedRxiv, 2021
3672021
SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape
S Cele, F Karim, G Lustig, JE San, T Hermanus, H Tegally, J Snyman, ...
Cell host & microbe 30 (2), 154-162. e5, 2022
1752022
Omicron BA. 4/BA. 5 escape neutralizing immunity elicited by BA. 1 infection
K Khan, F Karim, Y Ganga, M Bernstein, Z Jule, K Reedoy, S Cele, ...
Nature communications 13 (1), 4686, 2022
1482022
Escape of SARS-CoV-2 501Y
S Cele, I Gazy, L Jackson, SH Hwa, H Tegally, G Lustig, J Giandhari, ...
V2 variants from neutralization by convalescent plasma. medRxiv 2026 (10 …, 2021
1292021
Persistent SARS-CoV-2 infection and intra-host evolution in association with advanced HIV infection
F Karim, MYS Moosa, BI Gosnell, S Cele, J Giandhari, S Pillay, H Tegally, ...
MedRxiv, 2021.06. 03.21258228, 2021
1002021
Omicron sub-lineages BA. 4/BA. 5 escape BA. 1 infection elicited neutralizing immunity
K Khan, F Karim, Y Ganga, M Bernstein, Z Jule, K Reedoy, S Cele, ...
MedRxiv, 2022.04. 29.22274477, 2022
812022
Omicron infection enhances Delta antibody immunity in vaccinated persons
K Khan, F Karim, S Cele, K Reedoy, JE San, G Lustig, H Tegally, ...
Nature 607 (7918), 356-359, 2022
722022
SARS-CoV-2 spike T cell responses induced upon vaccination or infection remain robust against Omicron
R Keeton, MB Tincho, A Ngomti, R Baguma, N Benede, A Suzuki, K Khan, ...
MedRxiv, 2021.12. 26.21268380, 2021
602021
A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy
AJ Greaney, TN Starr, RT Eguia, AN Loes, K Khan, F Karim, S Cele, ...
PLoS pathogens 18 (2), e1010248, 2022
562022
Omicron infection of vaccinated individuals enhances neutralizing immunity against the Delta variant
K Khan, F Karim, S Cele, JE San, G Lustig, H Tegally, Y Rosenberg, ...
Medrxiv, 2022
542022
Network for Genomic Surveillance in South Africa; COMMIT-KZN Team, Lessells RJ, de Oliveira T, Sigal A. Escape of SARS-CoV-2 501Y. V2 from neutralization by convalescent plasma
S Cele, I Gazy, L Jackson, SH Hwa, H Tegally, G Lustig, J Giandhari, ...
Nature 593 (7857), 142-146, 2021
472021
HIV status alters disease severity and immune cell responses in beta variant SARS-CoV-2 infection wave
F Karim, I Gazy, S Cele, Y Zungu, R Krause, M Bernstein, K Khan, ...
Elife 10, e67397, 2021
462021
SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection. medRxiv. 2021: 2021.12. 08.21267417
S Cele, L Jackson, K Khan, D Khoury, T Moyo-Gwete, H Tegally
DOI 10 (2021.12), 08.21267417, 2021
412021
The continuous evolution of SARS-CoV-2 in South Africa: a new lineage with rapid accumulation of mutations of concern and global detection
C Scheepers, J Everatt, DG Amoako, A Mnguni, A Ismail, B Mahlangu, ...
Medrxiv, 2021
402021
NGS-SA; COMMIT-KZN Team
S Cele, L Jackson, DS Khoury, K Khan, T Moyo-Gwete, H Tegally, JE San, ...
Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization …, 2022
372022
SARS-CoV-2 Omicron spike mediated immune escape and tropism shift
B Meng, IATM Ferreira, A Abdullahi, N Goonawardane, A Saito, I Kimura, ...
BioRxiv, 2021.12. 17.473248, 2021
352021
Immunogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and Ad26. CoV2. S vaccination in people living with human immunodeficiency virus (HIV)
K Khan, G Lustig, M Bernstein, D Archary, S Cele, F Karim, M Smith, ...
Clinical Infectious Diseases 75 (1), e857-e864, 2022
332022
系统目前无法执行此操作,请稍后再试。
文章 1–20